Evidence map›Paper›PMID 40303259›Full record

ArticlePediatric diabetes2023

Impact of 6 months' Use of Intermittently Scanned Continuous Glucose Monitoring on Habitual Sleep Patterns and Sleep Quality in Adolescents and Young Adults with Type 1 Diabetes and High-Risk HbA1c.

Shelley Rose, Barbara C Galland, Sara E Styles, Esko J Wiltshire, James Stanley, Martin I de Bock, Paul A Tomlinson, Jenny A Rayns, Benjamin J Wheeler

Abstract read
In one paragraph

Article in Pediatric diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shelley RoseDepartment of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.ORCID 0000-0001-9733-3829
Barbara C GallandDepartment of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.ORCID 0000-0002-2376-3575
Sara E StylesDepartment of Human Nutrition, University of Otago, Dunedin, New Zealand.ORCID 0000-0002-8358-881X
Esko J WiltshireDepartment of Pediatrics and Child Health, University of Otago Wellington, Wellington, New Zealand.ORCID 0000-0002-8962-2708
James StanleyBiostatistical Group, Dean's Department, University of Otago Wellington, Wellington, New Zealand.ORCID 0000-0002-8572-1047
Martin I de BockDepartment of Pediatrics, University of Otago, Christchurch, New Zealand.ORCID 0000-0003-0454-6679
Paul A TomlinsonPediatric Department, Te Whatu Ora Southern, Invercargill, New Zealand.
Jenny A RaynsEndocrinology Department, Te Whatu Ora Southern, Dunedin, New Zealand.
Benjamin J WheelerDepartment of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.ORCID 0000-0003-3348-5238

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The bidirectional relationship between sleep and blood glucose levels may particularly affect adolescents and young adults (AYA), who are more likely to experience less healthy glycemic outcomes and more disrupted sleep patterns. To date, few data exist describing the impact of intermittently scanned continuous glucose monitoring (isCGM) on habitual sleep patterns and sleep quality in AYA with type 1 diabetes (T1D). Objective: To evaluate the impact of 6-month use of isCGM on habitual sleep and wake timing, sleep duration, frequency, and duration of night-time awakenings, sleep efficiency, and perceived sleep quality in young people with T1D and HbA1c ≥ 75 mmol/mol. Methods: Participants completed 7-day actigraphy measures and the Pittsburgh Sleep Quality Index questionnaire at the baseline and at 6 months. Regression analyses were used to model between-group comparisons, adjusted for baseline sleep measures. Results: At 6 months, subjective measures for overall sleep quality, latency, duration, efficiency, night-time disturbances, use of sleep medications, and daytime dysfunction were similar between the groups. Regression analyses of actigraphy found no significant differences in objectively measured sleep timing and duration across the week after adjusting for age, the period of the school year, and baseline sleep values. Conclusions: The use of first-generation isCGM in addition to finger-prick testing did not impact objective or subjective sleep measures in AYA with T1D, elevated HbA1c, and highly variable sleep patterns. Research using alternative interventions for improving glycemic outcomes and habitual sleep-wake timing, duration, and perceived sleep quality is warranted in this population group.

Indexed as

Blood Glucose Self-MonitoringDiabetes Mellitus, Type 1Glycated HemoglobinSleepSleep QualityAdolescentBlood GlucoseContinuous Glucose MonitoringFemaleHumansMaleYoung AdultBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID40303259
PMCPMC12016692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.